Adverse health events experienced by the recipients of COVID-19 vaccines and the associated factors in southwestern Saudi Arabia
http://dx.doi.org/10.21161/mjm.220088
- Author:
Ashraf Ewis
1
,
2
;
Omer Abdelbagi
3
;
Marwa Abdelrahim
2
;
Eman Ghazawy
2
;
Shaza Fadel
2
;
Doaa Mahmoud Khalil
4
;
Omar AlHazazi
5
;
Mosad Odah
6
;
Mohamed Elhefny
7
,
8
Author Information
1. Department of Public Health, Faculty of Health Sciences-AlQunfudah, Umm Al-Qura University, Makkah, Saudi Arabia&
2. Department of Public Health and Occupational Medicine, Faculty of Medicine, Minia University, El-Minia, Egypt.
3. Department of Pathology, Faculty of Medicine-AlQunfudah, Umm Al-Qura University, Makkah, Saudi Arabia
4. Department of Public Health and Community Medicine, Faculty of Medicine, Beni Suef University, Beni Suef, Egypt
5. Department of Chemistry, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia
6. Department of Biochemistry, Faculty of Medicine-AlQunfudah, Umm Al-Qura University, Makkah, Saudi Arabia
7. Department of Genetics, Faculty of Medicine-AlQunfudah, Umm Al-Qura University, Makkah, Saudi Arabia&
8. Department of Cancer and Molecular Biology, NCI Cairo University, Cairo, Egypt
- Publication Type:Journal Article
- Keywords:
AstraZeneca;
Pfizer BioNTech;
COVID-19 pandemic;
vaccine adverse events;
Saudi Arabia
- From:Malaysian Journal of Microbiology
2023;19(no.2):166-174
- CountryMalaysia
- Language:English
-
Abstract:
Aims:Studying the post-vaccination adverse health events is crucial to determine the confidence and acceptance of the public to the newly-developed COVID-19 vaccines. The present study aimed to investigate the prevalence rates of the adverse health events experienced by the recipients of COVID-19 vaccines in Saudi Arabia.
Methodology and results:A cross-sectional study was conducted in October 2021 using a google form of an online self-administered questionnaire sent via different social media platforms for recruiting participants from southwestern Saudi Arabia. The questionnaire was prepared by medical and public health professionals and then translated into Arabic, pilot-studied and validated. Among the 453 Saudi adults who participated in the study with at least one dose of the COVID-19 vaccine, about (77.9%) were males aged 25.5 ± 10.6 years. Most of the participants were college students living in the Makkah region. Nearly 68.3% reported post-vaccination adverse events, such as injection site pain/swelling (91.9%), fatigue (67.9%), bone and muscle pain (65.2%) and flu-like symptoms (58%). The type of vaccine was significantly associated with the development of adverse events p=0.002 (OR of Pfizer-BioNTech versus AstraZeneca: 0.33, 95% CI: 0.18-0.61). Additionally, ageing of more than the 3rd decade, male gender and being married were significantly associated with lower rates of reporting post-vaccination adverse events.
Conclusion, significance and impact of study:The development of COVID-19 vaccine-related adverse health events had no significant associations with residence, education, occupation, BMI, chronic diseases or smoking. However, age, gender, marital state and vaccine type may be considered significant predictors for developing post-vaccination adverse
reactions.
- Full text:20.2023my0019.pdf
